It all depends on the structure of the deal so can’t say if it’ll be a positive/negative impact until it’s signed and announced and we can review it. These deals aren’t easy to get off the ground so I don’t think we should interpret this as a promise.
The UK deal announcement didn’t have much impact on the share price which was an undersell of the value of that deal. UK revenue is $1m per year and to get $6.5m in media for 20% stake values the UK company at $32.5m Which is a 32x revenue multiple which is huge. (Airtasker global revenue multiple is 2.5x hence the current value at 110m)
So the deal was very favourable for Airtasker and says a professional analyst saw good value in that deal (albeit a media for equity swap they can probably be more lenient than a cash for equity swap).
I’d be very positive on a US deal and think it’s required for fast growth in US. US TV market is much more fragmented than UK or AU so again it entirely comes down to the individual deal they land if they can land one.
if the deals a good one where media offered is A grade TV ad spots it could be a game changer. If we’re given the off peak ad spots they couldn’t sell it’s obviously way less valuable. Though them being a part owner in Airtasker should protect them from this as why would they bother if they were just offloading junk tv spots.
- Forums
- ASX - By Stock
- ASX: ART ( Airtasker ): Significantly below fair value || $0.27 (current price) versus $0.64 (fair value)
It all depends on the structure of the deal so can’t say if...
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ART (ASX) to my watchlist
(20min delay)
|
|||||
Last
24.5¢ |
Change
-0.015(5.77%) |
Mkt cap ! $110.8M |
Open | High | Low | Value | Volume |
26.0¢ | 26.5¢ | 24.5¢ | $77.57K | 302.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 41756 | 24.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
26.0¢ | 5000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 41756 | 0.245 |
7 | 37874 | 0.240 |
2 | 6380 | 0.235 |
10 | 127811 | 0.230 |
1 | 45454 | 0.220 |
Price($) | Vol. | No. |
---|---|---|
0.260 | 5000 | 1 |
0.270 | 49950 | 6 |
0.275 | 50698 | 4 |
0.280 | 26081 | 6 |
0.285 | 35000 | 1 |
Last trade - 16.10pm 06/05/2024 (20 minute delay) ? |
|
|||||
Last
24.5¢ |
  |
Change
-0.015 ( 5.84 %) |
|||
Open | High | Low | Volume | ||
25.5¢ | 26.0¢ | 24.5¢ | 78370 | ||
Last updated 15.36pm 06/05/2024 ? |
Featured News
ART (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, CEO
Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online